Influence of the displacement of protein binding by ibuprofen in the activity of a third-generation cephalosporin against Streptococcus pneumoniae;Influencia del desplazamiento de la unión a proteínas por ibuprofeno en la actividad de una cefalosporina de tercera generación frente a Streptococcus pneumoniae

Revista Espanola de Quimioterapia

Volumn 19, Issue 4, 2006, Pages 332-336

  Cafini, F ^a   Gonzalez N ^a   Torrico, M ^a   Echeverria O ^a   Sevillano, D ^a   Alou, L ^a   Gimenez M J ^a   Aguilar, L ^a   Gomez Lus M L ^a   Prieto, José Prieto ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cefditoren; Ibuprofen; Protein binding; Streptococcus pneumoniae

Indexed keywords

ALBUMIN; AMOXICILLIN; CEFDITOREN; IBUPROFEN; PENICILLIN G;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN BINDING; STREPTOCOCCUS PNEUMONIA;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BINDING, COMPETITIVE; BLOOD PROTEINS; CEPHALOSPORINS; DRUG INTERACTIONS; DRUG RESISTANCE; HUMANS; IBUPROFEN; MICROBIAL SENSITIVITY TESTS; PROTEIN BINDING; SERUM ALBUMIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 33846880916     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Moellering, R.C., Eliopoulos, G.M. Principles of anti-infective therapy. En: Mandell, G.L., Bennett, J.E., Dolin, R. (Eds.). Mandell, Douglas and Bennett Principles and practice of infectious diseases, 6th ed. Elsevier Churchill Livingstone, Philadelphia 2005; 242-253.
2. Cha, R., Rybak, M.J. Influence of protein binding under controlled conditions on the bactericidal activity of daptomycin in an in vitro pharmacodynamic model. J Antimicrob Chemother 2004; 54: 259-262.
3. Palmer, S. M., Kang, S.L., Cappelletty, D.M., Rybak, M.J. Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and betalactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model. Antimicrob Agents Chemother 1995; 39: 1764-1771.
4. Boswell, F. J., Ashby, J.P., Andrews, J.M., Wise, R. Effect of protein binding on the in vitro activity and pharmacodynamics of faropenem. J Antimicrob Chemother 2002; 50: 525-532.
5. Armijo, J.A. Absorción, distribución y eliminación de los fármacos. En: Flórez, J., Armijo, J.A., Mediavilla, A. (Eds.). Farmacología humana. Masson, Barcelona 1987; 57-68.
6. Tsivou, E., Melakopoulos, I., Kotsiou, A., Anagnostopoulou, S., Tesseromatis, C. Alterations in cefalosporin levels in the serum and mandible of hyperlipaedemic rats after co-administration of ibuprofen. Eur J Drug Metab Pharmacokinet 2005; 30: 171-174.
7. Bialer, M., Wu, W.H., Faulkner, R.D., Silber, B.M., Yacobi, A. In vitro protein binding interaction studies involving cefixime. Biopharm Drug Dispos 1988; 9: 315-320.
8. Soriano, F., Granizo, J.J., Fenoll, A. y cols. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae isolated in four Southern European countries (ARISE Project) from adult patients: Results from the Cefditoren Surveillance Program. J Chemother 2003; 15: 107-112.
9. Wellington, K., Curran, M.P. Cefditoren pivoxil: A review of its use in the treatment of bacterial infections. Drugs 2004; 64: 2597-2618.
10. Kapil, R., Nolting, A., Roy, P., Fiske, W., Benedek, I., Abramowitz, W. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: Two randomized, open-label, cross-over studies in healthy adult volunteers. Clin Ther 2004; 26: 2015-2025.
11. Spangler, S.K., Jacobs, M.R., Appelbaum, P.C. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams. J Antimicrob Chemother 1997; 39: 141-148.
12. Casal, J., Aguilar, E., Jado, I. y cols. Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model. Antimicrob Agents Chemother 2002; 46: 1340-1344.
13. Casal, J., Giménez, M.J., Aguilar, E. y cols. Beta-lactam activity against resistant pneumococcal strains is enhanced by the immune system. J Antimicrob Chemother 2002; 50 (Suppl. S2): 83-86.